Collectively, these results suggest that schizophrenia-associated Arhgap10 gene variants result in morphological abnormalities of neurons in the mPFC, and these abnormalities are associated with vulnerability to cognitive deficits induced by methamphetamine treatment. The gene discussed is ARHGAP10; the disease is Cognitive impairment.